Opportunity ID: 331382

General Information

Document Type: Grants Notice
Funding Opportunity Number: W81XWH-21-OCRP-CTRA
Funding Opportunity Title: CDMRP Ovarian Cancer Clinical Translational Research Award
Opportunity Category: Discretionary
Opportunity Category Explanation:
Funding Instrument Type: Cooperative Agreement
Grant
Category of Funding Activity: Science and Technology and other Research and Development
Category Explanation:
Expected Number of Awards: 4
Assistance Listings: 12.420 — Military Medical Research and Development
Cost Sharing or Matching Requirement: No
Version: Synopsis 1
Posted Date: Feb 08, 2021
Last Updated Date: Feb 08, 2021
Original Closing Date for Applications: Jul 08, 2021
Current Closing Date for Applications: Jul 08, 2021
Archive Date: Aug 07, 2021
Estimated Total Program Funding: $2,880,000
Award Ceiling:
Award Floor:

Eligibility

Eligible Applicants: Unrestricted (i.e., open to any type of entity above), subject to any clarification in text field entitled “Additional Information on Eligibility”
Additional Information on Eligibility:

Additional Information

Agency Name: Dept. of the Army — USAMRAA
Description:

The Clinical Translational Research Award is intended to support correlative studies that are associated with a clinical trial. The translational research should address high-impact or unmet needs in ovarian cancer. Applications focused on the following OCRP priority are encouraged to apply:

*          Utilize precision medicine and computational approaches that identify individual tumor characteristics and predictive biomarkers across diverse groups to optimize patient care and outcomes

Although not intended to fund the operational aspects of clinical trials, this award supports research projects related to or associated with planned, ongoing, or completed clinical trials supported by other funding sources. Projects that develop clinical endpoints for clinical trials are also encouraged. The application must demonstrate availability and accessibility of the appropriate human subject population, specimens, or human-based resources. The application should also provide a detailed statistical analysis plan that includes a power analysis reflecting sample size projections that will allow a meaningful outcome. Preclinical studies in animals are not allowed. 

Link to Additional Information:
Grantor Contact Information: If you have difficulty accessing the full announcement electronically, please contact:

CDMRP Help Desk

Phone: 301-682-5507

Email: help@eBRAP.org
Email:help@eBRAP.org

Version History

Version Modification Description Updated Date

Folder 331382 Full Announcement-FY21 OCRP CTRA -> OCRP_FY21 CTRA PA.pdf

Packages

Agency Contact Information: CDMRP Help Desk
Phone: 301-682-5507
Email: help@eBRAP.org
Email: help@eBRAP.org
Who Can Apply: Organization Applicants

Assistance Listing Number Competition ID Competition Title Opportunity Package ID Opening Date Closing Date Actions
12.420 PKG00265335 Feb 08, 2021 Jul 08, 2021 View

Package 1

Mandatory forms

331382 RR_SF424_3_0-3.0.pdf

331382 AttachmentForm_1_2-1.2.pdf

331382 RR_PersonalData_1_2-1.2.pdf

331382 RR_KeyPersonExpanded_3_0-3.0.pdf

331382 RR_Budget_1_4-1.4.pdf

331382 PerformanceSite_3_0-3.0.pdf

Optional forms

331382 RR_SubawardBudget30_1_4-1.4.pdf

2025-07-11T05:44:03-05:00

Share This Post, Choose Your Platform!

About the Author: